MEDICAL ONCOLOGY SCIE
医学肿瘤学
1357-0560
Quarterly
No
MED ONCOL
1994
187
UNITED STATES
http://link.springer.com/journal/12032
平均1.4月审稿时间
约63.33%平均录用比例
3.5影响因子
肿瘤学小学科
106/326JIF RANK
7563总被引频次
1357-0560
Quarterly
No
MED ONCOL
1994
187
UNITED STATES
http://link.springer.com/journal/12032
平均1.4月审稿时间
约63.33%平均录用比例
3.5影响因子
肿瘤学小学科
106/326JIF RANK
7563总被引频次
由斯普林格出版。国际标准书号：1357-0560。医学肿瘤学（MO）将肿瘤学和血液学的临床和实验研究结果，特别是与免疫治疗和化疗领域的实验治疗学进行交流。它还为肿瘤和血液学的临床和实验治疗提供了最新的回顾。课程包括免疫生物学、发病机制和恶性肿瘤的治疗。涵盖肿瘤学和血液学的临床和实验研究专注于免疫治疗和化疗领域的实验治疗覆盖范围包括免疫生物学、发病机制和恶性肿瘤的治疗。
http://www.edmgr.com/medo/
Published by Springer.ISSN: 1357-0560.Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors. Covers clinical and experimental research in oncology and hematology Focuses on experimental therapeutics in the field of immunotherapy and chemotherapy Coverage includes immunobiology, pathogenesis, and treatment of malignant tumors
